Evaluation of Dexmedetomidine as an Adjunct to Phenobarbital for Alcohol Withdrawal in Critically Ill Patients.
Lydia R WareBrian R SchulerMelanie Z GoodberletKaylee K MarinoKenneth E LupiJeremy R DeGradoPublished in: Journal of intensive care medicine (2023)
This analysis suggests the use of adjunctive DEX with PHB for AWS was associated with a prolonged ICU LOS. Additional studies are needed to further understand the role of adjunctive DEX in the treatment of AWS in critically ill patients.